ReviewAdvanced healthcare materials2026
Magnetically Driven Biofabrication for Tissue Engineering: From Nanoparticle Design to Mag-ATMP Translation.
Review in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Magnetically driven biofabrication is emerging as a materials-enabled extension of tissue engineering, integrating advances in magnetic nanoparticle (MNP) design with cells, spheroids, and biomaterial scaffolds to engineer responsive and remotely controllable living systems. Progress in nanoparticle engineering has yielded biocompatible and tunable MNP formulations that can be incorporated into hydrogels, spheroids, organoids, and scaffolds, where they influence cellular behavior, extracellular matrix organization, and mechanotransduction. Externally applied magnetic fields further enable non-contact control over cell positioning, microtissue assembly, matrix alignment, and dynamic mechanical stimulation, expanding the design space of 3D and 4D biofabrication. This Review critically maps and unifies the multiscale design principles underlying magnetically driven biofabrication, spanning nanoparticle design, magnetic actuation strategies, and biological responses. We compare approaches ranging from single-cell manipulation and magnetoactive bioinks to spheroid fusion and microfluidic systems with embedded magnetic actuation. We further discuss how physics-based modeling, data-informed optimization, and emerging digital twin concepts may help connect material properties, magnetic field design, and biological response. Finally, we examine translational considerations, including Good Manufacturing Practice (GMP)-compatible nanoparticle formulations, mechanistic clarity, long-term safety evaluation, and regulatory alignment, converging toward magnetically enabled tissue-engineered advanced therapy medicinal products (Mag-TE ATMPs).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.